Hydroxyapatite scaffolds infiltrated with thermally crosslinked polycaprolactone fumarate and polycaprolactone itaconate

Journal of Biomedical Materials Research - Part A

Volumn 98 A, Issue 2, 2011, Pages 257-267

  Sharifi, Shahriar ^a,b,e   Shafieyan, Yousef ^c,f   Mirzadeh, Hamid ^b   Bagheri Khoulenjani, Shadab ^b   Rabiee, Sayed Mahmood ^d   Imani, Mohammad ^a   Atai, Mohammad ^a   Shokrgozar, Mohammad Ali ^c   Hatampoor, Ali ^b  

^a IRAN POLYMER AND PETROCHEMICAL INSTITUTE   (Iran)

^b AMIRKABIR UNIVERSITY OF TECHNOLOGY   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d BABOL NOSHIRVANI UNIVERSITY OF TECHNOLOGY   (Iran)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

crosslinking; hydroxyapatite; infiltration; unsaturated polycaprolactone

Indexed keywords

CELL LINES; CROSSLINKED; DEGREE OF SUBSTITUTION; FUMARATES; FUMARYL CHLORIDE; IN-VITRO; INFILTRATING POLYMERS; LOW MOLECULAR WEIGHT; MACROMERS; OSTEOGENIC; POLYCAPROLACTONE FUMARATE; POLYESTERIFICATION; POLYESTERIFICATION REACTION; POLYMER INFILTRATION; POROSIMETRY; REINFORCEMENT EFFECTS; REPLICATION TECHNIQUES; SARCOMA CELLS; THERMAL CROSSLINKING; UNSATURATED POLYCAPROLACTONE;

APATITE; BIOMECHANICS; CELL CULTURE; COMPRESSIVE STRENGTH; DICHLOROMETHANE; DIFFERENTIAL SCANNING CALORIMETRY; ESTERS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GEL PERMEATION CHROMATOGRAPHY; HYDROXYAPATITE; MECHANICAL PROPERTIES; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYCAPROLACTONE; POLYMERS; RESONANCE; SCANNING ELECTRON MICROSCOPY; SEEPAGE; SINTERING; SIZE EXCLUSION CHROMATOGRAPHY; SOIL MECHANICS; UNSATURATED POLYMERS;

SCAFFOLDS (BIOLOGY);

CHLORIDE; DICHLOROMETHANE; FUMARIC ACID DERIVATIVE; HYDROXYAPATITE; ITACONIC ACID; POLYCAPROLACTONE; POLYCAPROLACTONE FUMARATE; POLYCAPROLACTONE ITACONATE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL MODIFICATION; COMPRESSIVE STRENGTH; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; ESTERIFICATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; POROSITY; PROTON NUCLEAR MAGNETIC RESONANCE; SARCOMA CELL; SUBSTITUTION REACTION; SYNTHESIS;

CELL LINE, TUMOR; CELL SURVIVAL; CROSS-LINKING REAGENTS; CRYSTALLIZATION; DURAPATITE; FUMARATES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MECHANICAL PHENOMENA; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR WEIGHT; POLYESTERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TEMPERATURE; TISSUE SCAFFOLDS;

EID: 79959529821     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33108     Document Type: Article

References (36)

1. Barrere F, van Blitterswijk CA, de Groot K,. Bone regeneration: Molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomedicine 2006; 1: 317-332.
2. Liu Q, de Wijn JR, de Groot K, van Blitterswijk CA,. Surface modification of nano-apatite by grafting organic polymer. Biomaterials 1998; 19: 1067-1072. (Pubitemid 28327534)
3. Pezzotti G, Asmus SMF,. Fracture behavior of hydroxyapatite/polymer interpenetrating network composites prepared by in situ polymerization process. Mater Sci Eng A 2001; 316: 231-237. (Pubitemid 32914347)
4. Causa F, Netti PA, Ambrosio L, Ciapetti G, Baldini N, Pagani S, Martini D, Giunti A,. Poly-epsilon-caprolactone/hydroxyapatite composites for bone regeneration: In vitro characterization and human osteoblast response. J Biomed Mater Res A 2006; 76: 151-162. (Pubitemid 43075693)
5. Yunos DM, Bretcanu O, Boccaccini AR,. Polymer-bioceramic composites for tissue engineering scaffolds. J Mater Sci 2008; 43: 4433-4442.
6. Komlev VS, Barinov SM, Rustichelli F,. Strength enhancement of porous hydroxyapatite ceramics by polymer impregnation. J Mater Sci Lett 2003; 22: 1215-1217.
7. Pezzotti G, Asmus SMF, Ferroni LP, Miki S,. In situ polymerization into porous ceramics: A novel route to tough biomimetic materials. J Mater Sci Mater Med 2002; 13: 783-787. (Pubitemid 34879425)
8. Supova M,. Problem of hydroxyapatite dispersion in polymer matrices: A review. J Mater Sci Mater Med 2009; 20: 1201-1213.
9. Miao X, Lim WK, Huang X, Chen Y,. Preparation and characterization of interpenetrating phased TCP/HA/PLGA composites. Mater Lett 2005; 59: 4000-4005. (Pubitemid 41460476)
10. Miao XG, Tan DM, Li J, Xiao Y, Crawford R,. Mechanical and biological properties of hydroxyapatite/tricalcium phosphate scaffolds coated with poly(lactic-co-glycolic acid). Acta Biomater 2008; 4: 638-645. (Pubitemid 351461279)
11. Kim HW, Knowles JC, Kim HE,. Hydroxyapatite/poly(epsilon-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 2004; 25: 1279-1287. (Pubitemid 37476205)
12. Kim HW, Knowles JC, Kim HE,. Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release. J Mater Sci Mater Med 2005; 16: 189-195. (Pubitemid 40386272)
13. Shor L, Guceri S, Wen XJ, Gandhi M, Sun W,. Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro. Biomaterials 2007; 28: 5291-5297. (Pubitemid 47532190)
14. Wong SC, Baji A, Gent AN,. Effect of specimen thickness on fracture toughness and adhesive properties of hydroxyapatite-filled polycaprolactone. Compos A 2008; 39: 579-587. (Pubitemid 351380975)
15. Tencer AF, Woodard PL, Swenson J, Brown KL,. Bone Ingrowth Into Polymer Coated Porous Synthetic Coralline Hydroxyapatite. J Orthop Res 1987; 5: 275-282. (Pubitemid 17088151)
16. Brodie JC, Merry J, Grant MH,. The mechanical properties of calcium phospate ceramics modified by collagen coating and populated by osteoblasts. J Mater Sci Mater Med 2006; 17: 43-48. (Pubitemid 43042227)
17. Baji A, Wong SC, Srivatsan TS, Njus GO, Mathur G,. Processing methodologies for polycaprolactone-hydroxyapatite composites: A review. Mater Manufacturing Processes 2006; 21: 211-218. (Pubitemid 43328841)
18. Goldberg D,. A Review of the Biodegradability and Utility of Poly(Caprolactone). J Environ Polym Degrad 1995; 3: 61-67.
19. Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC,. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res 2001; 55: 203-216. (Pubitemid 32198503)
20. Williams JM, Adewunmi A, Schek RM, Flanagan CL, Krebsbach PH, Feinberg SE, Hollister SJ, Das S,. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 2005; 26: 4817-4827. (Pubitemid 40347312)
21. Hakala RA, Korhonen H, Holappa S, Seppala JV,. Hydrophobicities of poly(epsilon-caprolactone) oligomers functionalized with different succinic anhydrides. Eur Polym J 2009; 45: 557-564.
22. Meretoja VV, Helminen AO, Korventausta JJ, Haapa-aho V, Seppala JV, Narhi TO,. Crosslinked poly(epsilon-caprolactone/D,L-lactide)/bioactive glass composite scaffolds for bone tissue engineering. J Biomed Mater Res A 2006; 77: 261-268. (Pubitemid 47233527)
23. Grijpma DW, Hou QP, Feijen J,. Preparation of biodegradable networks by photo-crosslinking lactide, epsilon-caprolactone and trimethylene carbonate-based oligomers functionalized with fumaric acid monoethyl ester. Biomaterials 2005; 26: 2795-2802. (Pubitemid 39647219)
24. Shafieyan Y, Sharifi S, Imani M, Shokrgozar MA, Aboudzadeh N, Atai M,. A biocompatible composite based on poly(ε-caprolactone fumarate) and hydroxyapatite. Polym Adv Technol 22, doi: 10.1002/pat.1743.
25. Wang SF, Kempen DHR, Yaszemski MJ, Lu LC,. The roles of matrix polymer crystallinity and hydroxyapatite nanoparticles in modulating material properties of photo-crosslinked composites and bone marrow stromal cell responses. Biomaterials 2009; 30: 3359-3370.
26. Sharifi S, Mirzadeh H, Imani M, Ziaee F, Tajabadi M, Jamshidi A, Atai M,. Synthesis, photocrosslinking characteristics, and biocompatibility evaluation of N-vinyl pyrrolidone/polycaprolactone fumarate biomaterials using a new proton scavenger. Polym Adv Technol 2008; 19: 1828-1838.
27. Jabbari E, Wang SF, Lu LC, Gruetzmacher JA, Ameenuddin S, Hefferan TE, Currier BL, Windebank AJ, Yaszemski MJ,. Synthesis, material properties, and biocompatibility of a novel self-cross-linkable poly(caprolactone fumarate) as an injectable tissue engineering scaffold. Biomacromolecules 2005; 6: 2503-2511. (Pubitemid 41388260)
28. Wang SF, Lu LC, Gruetzmacher JA, Currier BL, Yaszemski MJ,. Synthesis and characterizations of biodegradable and crosslinkable poly(epsilon-caprolactone fumarate), poly(ethylene glycol fumarate), and their amphiphilic copolymer. Biomaterials 2006; 27: 832-841. (Pubitemid 41484115)
29. Sharifi S, Kamali M, Mohtaram NK, Shokrgozar MA, Rabiee SM, Atai M, Imani M, Mirzadeh H,. Preparation, mechanical properties, and in vitro biocompatibility of novel nanocomposites based on polyhexamethylene carbonate fumarate and nanohydroxyapatite. Polym Adv Technol 2011; 22: 605-611.
30. Deb S, khorasani sn, Behiri JC, Braden M, Bonfield W,. Modified hydroxyapatite reinforced PEMA bone cement. Bioceramics 1992; 5: 225-232.
31. Sharifi S, Mirzadeh H, Imani M, Atai M, Ziaee F,. Photopolymerization and shrinkage kinetics of in situ crosslinkable N-vinyl-pyrrolidone/poly(epsilon- caprolactone fumarate) networks. J Biomed Mater Res A 2008; 84: 545-556.
32. Tawfik SY, Asaad JN, Sabaa MW,. Effect of polyester backbone structure on the cured products properties. Polym Test 2003; 22: 747-759.
33. Komlev VS, Barinov SM, Rustichelli F,. Strength enhancement of porous hydroxyapatite ceramics by polymer impregnation. J Mater Sci Lett 2003; 22: 1215-1217.
34. Dvorak MM, Riccardi D,. Ca2+ as an extracellular signal in bone. Cell Calcium 2004; 35: 249-255.
35. Loza J, Carpio L, Lawless G, Marzec N, Dziak R,. Role of Extracellular Calcium Influx in Egf-Induced Osteoblastic Cell-Proliferation. Bone 1995; 16: S341-S347.
36. Sharifi S, Mirzadeh H, Imani M, Rong Z, Jamshidi A, Shokrgozar M, Atai M, Roohpour N,. Injectable in situ forming drug delivery system based on poly(epsilon-caprolactone fumarate) for tamoxifen citrate delivery: Gelation characteristics, in vitro drug release and anti-cancer evaluation. Acta Biomater 2009; 5: 1966-1978.